Characterization of the clinical and laboratory phenotype of hemophilia carriers and trends of utilization of hemostatic therapies: analysis of the American Thrombosis and Hemostasis Network dataset.

Res Pract Thromb Haemost · 2025 · PMC12454875 · PMID 40994888

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Our analysis reveals an increasing trend in the utilization of factor concentrates and other nonfactor hemostatic therapies, including DDAVP and antifibrinolytics among carriers.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.